Skip to main content
. Author manuscript; available in PMC: 2022 Jan 10.
Published in final edited form as: Pharmacol Ther. 2020 Nov 24;221:107747. doi: 10.1016/j.pharmthera.2020.107747

Fig. 2.

Fig. 2.

Schematic representation showing the use of Hsp90 inhibitors and their role in human diseases. (A) Stepwise (I-VIII) protein folding mechanism by Hsp90 as described (Garg et al., 2016). (B) Hsp90 drug discovery process. Created with BioRender.com